These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 18415763)
41. Explaining the natural course of gout to people living in the tropics. Jatuworapruk K; Dalbeth N Int J Rheum Dis; 2021 Jun; 24(6):858-859. PubMed ID: 34028965 [No Abstract] [Full Text] [Related]
42. Uric acid nephropathy as an unusual cause of actual renal failure in a neonate. Shenoi A; Phadke KD Indian Pediatr; 2000 Mar; 37(3):322-4. PubMed ID: 10750078 [No Abstract] [Full Text] [Related]
44. Recurrent Gout and Serum Urate. Shan D JAMA; 2024 May; 331(20):1767-1768. PubMed ID: 38696164 [No Abstract] [Full Text] [Related]
45. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial. Schumacher HR; Becker MA; Wortmann RL; Macdonald PA; Hunt B; Streit J; Lademacher C; Joseph-Ridge N Arthritis Rheum; 2008 Nov; 59(11):1540-8. PubMed ID: 18975369 [TBL] [Abstract][Full Text] [Related]
46. [Threatening urate and gout]. de Haas WH Ned Tijdschr Geneeskd; 1974 Dec; 118(52):1960-5. PubMed ID: 4612388 [No Abstract] [Full Text] [Related]
47. Q: should patients with gout avoid thiazides for hypertension? Mandell BF Cleve Clin J Med; 2014 Feb; 81(2):83-6. PubMed ID: 24493485 [No Abstract] [Full Text] [Related]
48. [Uric acid and diabetes mellitus]. Kostrzewa-Zabłocka E Przegl Lek; 2004; 61(9):945-6. PubMed ID: 15803905 [No Abstract] [Full Text] [Related]
52. [Inflammasome and gout]. Aringer M; Hedrich C; Tausche AK Z Rheumatol; 2016 Aug; 75(6):537-41. PubMed ID: 27418053 [No Abstract] [Full Text] [Related]
53. Febuxostat (Uloric) for chronic treatment of gout. Med Lett Drugs Ther; 2009 May; 51(1312):37-8. PubMed ID: 19448587 [TBL] [Abstract][Full Text] [Related]
54. Optimal management of chronic gout: attempting to render the (t)issues crystal-clear. Wong ML N Z Med J; 2005 Jun; 118(1217):U1533. PubMed ID: 15980907 [No Abstract] [Full Text] [Related]
55. [Advances in the management of gout]. Zaninetti-Schaerer A; Guerne PA Rev Med Suisse; 2007 Mar; 3(103):734-7. PubMed ID: 17458151 [TBL] [Abstract][Full Text] [Related]
56. Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study. Schumacher HR; Becker MA; Lloyd E; MacDonald PA; Lademacher C Rheumatology (Oxford); 2009 Feb; 48(2):188-94. PubMed ID: 19141576 [TBL] [Abstract][Full Text] [Related]
57. New drugs for crystal deposition diseases. McCarthy G Curr Opin Rheumatol; 2006 Mar; 18(2):170. PubMed ID: 16462523 [No Abstract] [Full Text] [Related]
58. Colchicine in acute gout: the need for a reappraisal. Varughese GI; Jammalamadaka D; Varghese AI; Babu S; Reddy M Int J Clin Pract; 2007 Dec; 61(12):2132-3. PubMed ID: 17997813 [No Abstract] [Full Text] [Related]
59. Update on the management of hyperuricemia and gout. Pillinger MH; Keenan RT Bull NYU Hosp Jt Dis; 2008; 66(3):231-9. PubMed ID: 18937638 [TBL] [Abstract][Full Text] [Related]
60. Information from your family doctor. Gout: what you should know. American Academy of family Physicians Am Fam Physician; 2007 Sep; 76(6):811-2. PubMed ID: 17910295 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]